Stojanović, Miloš, and Daliborka Bursać. 2024. “Immunotoxicity of Pembrolizumab in Patients With Metastatic Non-Small Cell Lung Cancer: A Single-Centre Study”. Archive of Oncology 30 (1): 14-18. https://doi.org/10.2298/AOO240304006S.